Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Free Cash Flow: 2020-2025

Historic Free Cash Flow for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to -$3.0 million.

  • iSpecimen's Free Cash Flow fell 148.82% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year decrease of 53.09%. This contributed to the annual value of -$8.9 million for FY2024, which is 6.87% up from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Free Cash Flow is -$3.0 million, which was down 1,478.88% from -$192,234 recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's Free Cash Flow peaked at $79,015 during Q4 2023, and registered a low of -$6.4 million during Q3 2021.
  • Moreover, its 3-year median value for Free Cash Flow was -$2.3 million (2024), whereas its average is -$2.1 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first surged by 104.84% in 2023, then plummeted by 4,704.03% in 2024.
  • Quarterly analysis of 5 years shows iSpecimen's Free Cash Flow stood at -$1.6 million in 2021, then declined by 0.61% to -$1.6 million in 2022, then spiked by 104.84% to $79,015 in 2023, then slumped by 4,704.03% to -$3.6 million in 2024, then slumped by 148.82% to -$3.0 million in 2025.
  • Its Free Cash Flow was -$3.0 million in Q3 2025, compared to -$192,234 in Q2 2025 and -$1.1 million in Q1 2025.